Recent development of molecular genetic techniques are rapidly advancing understanding of the functional role of brain circuits in behavior. Critical to this approach is the ability to target specific neuron populations and circuits. The collection of over 250 BAC Cre-recombinase driver lines produced by the GENSAT project provides a resource for such studies. Here we provide characterization of GENSAT BAC-Cre driver lines with expression in specific neuroanatomical pathways within the cerebral cortex and basal ganglia.
INTRODUCTION
Advances in molecular genetic techniques are revealing new details of the neuronatomical organization of brain circuitry and the functional role of these circuits in behavior (Luo et al., 2008; Huang and Zeng, 2013) . Engineered viral vector constructs have been developed to label axonal projections of targeted neurons with unprecedented clarity, while others allow for retrograde transsynaptic labeling of neurons providing inputs or anterograde transsynaptic labeling of postsynaptic targets of axonal projections. The development of optogenetic and designer receptors exclusively activated by designer drugs (DREADD) techniques has allowed investigators to functionally manipulate neural circuits to study their role in behavior, and calcium indicators allow physiologic activity to be analyzed in targeted neuron populations (Alexander et al., 2009; Fenno et al., 2011) . Together, these approaches are providing new insights into the functional organization of neural circuits. For example, optogenetic studies, using light activation of Channel Rhodopsin (ChR), have demonstrated the ability to functionally manipulate specific neural pathways to determine their role in behaviors including fear memory (Ehrlich et al., 2009) , anxiety (Tye et al., 2011) , feeding (Atasoy et al., 2012) , reward (Kravitz et al., 2012) , and movement (Kravitz et al., 2010) . The analytic potential of these approaches is enhanced by the ability to target specific neuron populations, which are defined components of neural circuits. One approach involves the use of transgenic Cre-driver mouse lines in which Cre-recombinase is expressed under the control of gene-specific promoters. In this study, we characterize BAC-Cre driver lines from the GENSAT project (Gong et al., 2007) that allow for targeting components of the neural circuits of the cerebral cortex and basal ganglia.
The adaptation of bacterial artificial chromosomes (BACs) to express enhanced GFP (EGFP) with specified gene promoters has proven to be an efficient strategy to generate transgenic mice with EGFP expression targeted to specific neuron populations (Heintz, 2001; Gong et al., 2003) . This approach was modified in the GENSAT project to generate over 250 BAC-Cre driver lines that display expression of Cre-recombinase in specific neuron and glial populations throughout the brain (Gong et al., 2007) . Characterization of Cre-expression in these lines was determined by crossing BAC-Cre driver lines with a Rosa26-EGFP reporter line and visualizing EGFP labeling in coronal and sagittal brain sections, which are presented on the GENSAT website (http://www.gensat.org). Although the GENSAT collection provides a large number of BAC-Cre driver lines, the nominal characterization provided has limited their usefulness for the research community. For example, although there are over 50 BAC-Cre lines with expression in specific cortical layers or areas, determination of specific cortical neuron subtypes requires information concerning their axonal projections. Moreover, the characterization of Cre expression obtained with the Rosa26-EGFP reporter line in some cases does not provide an accurate description of functional Cre-expression in the adult animal. In this study, we provide additional characterization of 100 GENSAT BAC-Cre driver lines. Additional characterization utilizes injection of viral vectors that provide for Cre-dependent labeling of axonal projections (Luo et al., 2008; Madisen et al., 2010) . This axonal tracing data are critical for distinguishing between subtypes of neuronal populations based on their connections. These data are presented on a website (http:// GENSATcreBrains.biolucida.net) that provides the ability to view high-resolution images of the neuroanatomical data in the context of the functional organization of cerebral cortical and basal ganglia circuits.
RESULTS
The major connections of the cerebral cortex and basal ganglia (Gerfen and Wilson, 1996) are diagrammed in Figure 1 .
Pyramidal neurons in different layers of the cerebral cortex are distinguished by their axonal projection patterns, with layer 2/3 neurons providing intracortical connections, layer 5 neurons providing projections to subcortical structures including the striatum, and layer 6 neurons providing projections to the thalamus. The principal neuron of the striatum is the spiny projection neuron. One subtype, the direct pathway neuron, projects directly to the output nuclei of the basal ganglia in the internal segment of the globus pallidus (GPi) and substantia nigra pars reticulata (SNr). The other subtype, the indirect striatal pathway neuron, projects only to the external segment of the globus pallidus (GPe), whose projections to the subthalamic nucleus (STN) and SNr provide indirect connections to the basal ganglia output nuclei. The output of the basal ganglia is directed to the thalamus, superior colliculus (SC), and other midbrain structures. Within each of these general classifications of neuron types, there are subtypes distinguished by their axonal projections. In this study, AAV-cre-dependent expression vectors are used to identify specific neuronal subtypes in BAC-Cre driver lines.
Several general issues concerning functional Cre-expression emerged from analysis of the BAC-Cre driver lines described. First, for most lines, expression patterns obtained with both the Rosa26-EGFP and Rosa26-(CAG)dTomato reporter lines are similar. However, in some lines, additional expression is revealed with the Rosa26-(CAG)dTomato reporter, indicating that the Rosa26-(CAG)dTomato reporter may be more sensitive.
Second, localized injections of AAV with Cre-dependent EGFP or dTomato expression constructs are used to determine whether such labeling occurs in the neuron population displaying Cre-dependent expression produced by crosses to the Rosa26-EGFP or Rosa26-(CAG)dTomato FLEX reporter lines. For most lines, neuronal labeling produced with AAV-Credependent expression constructs corresponds to that predicted by expression produced with the reporter lines. In some lines, AAV-Cre-dependent expression is produced in more neurons than is observed in brains from the reporter lines. This discrepancy is most often observed with AAV-expression vector injections into Cre lines crossed to the Rosa26-EGFP reporter. The Rosa26-(CAG)dTomato reporter provides a more accurate predictor of labeling obtained with AAV-expression vector injections. An example of this type of discrepancy between the Rosa26 reporter lines and the efficacy of AAV-expression vector injection labeling is provided by the Syt17_NO14 BACCre driver line described later in this study. A third issue is the absence of labeling with AAV-expression vector injections of neurons that display labeling with the Rosa26 reporters. This most likely occurs in BAC-Cre driver lines in which the gene promoter is transiently active during development but not in the adult. Additionally, the lines used are heterozygous for the BAC-Cre construct to maintain uniform expression and to minimize possible effects of overexpression of an exogenous protein on neuron function.
Taken together, these issues indicate the importance of characterizing BAC-Cre driver lines to be used for functional studies with multiple methods. In most cases, analysis of expression with Rosa26-EGFP or Rosa26-(CAG)dTomato reporter lines provides an accurate predictor of neurons that express functional Cre, which will express injected viral constructs. However, injections of AAV or other viral expression vectors facilitate the characterization of BAC-Cre driver lines for use in functional studies. In this study, we provide such analysis to identify BAC-Cre driver lines with functional Cre expression in identified neuron populations in the cerebral cortex and basal ganglia circuits.
Web-Based Database of BAC-Cre Lines
A list of GENSAT BAC-Cre driver lines is provided at http://www. gensat.org/cre.jsp. On this website, images of coronal and sagittal brain sections in the adult and at postnatal day 7 (P7) show expression displayed with the Rosa26-EGFP reporter line. In addition, these lines may be obtained from the Mutant Mouse Regional Resource Center (MMRRC), with a link on the website for each line. AAV-Cre-dependent expression vector injections that labeled axonal projections, as determined by additional characterization, are provided on a browser that can be downloaded from http://GENSATcreBrains.biolucida.net. Data on this website may be searched by specific BAC-Cre lines, neuronal subtypes, or brain structure.
Cortical Neurons
A list of GENSAT BAC-Cre lines with expression in the cerebral cortex is provided in Table 1 . Most of these lines have expression in other brain regions, but here are characterized on the basis of cortical expression, including expression in cortical layer and Corticostriatal inputs arise from two major subtypes: intertelencephalic (IT) corticostriatal neurons, which provide bilateral inputs to the striatum, and pyramidal tract (PT) corticostriatal neurons, which project an axon ipsilaterally with collaterals to the striatum, thalamus, subthalamic nucleus (STN), superior colliculus (SC), pons, and spinal cord. Two main subtypes of projection neurons in the striatum give rise to direct and indirect pathways. The direct pathway provides direct projections to the output nuclei of the basal ganglia, the internal segment of the globus pallidus (GPi), and the substantia nigra pars reticulata (SNr). The indirect pathway projects to the external segment of the globus pallidus (GPe), which connects indirectly through the STN to the GPi and SNr. The major output of the basal ganglia originates from GABAergic neurons in the GPi and SNr, which provide inhibitory input to the thalamus, SC, and pedunculopontine nucleus (PPN).
area determined with Cre-reporter expression and by neuron subtype determined by AAV-Cre-dependent expression vector injections to label axonal projection patterns.
Lines with Expression in Corticostriatal Projection
Neurons Virtually all areas of the cerebral cortex provide excitatory inputs to the striatum that target spiny projection neurons, as well as interneurons. Corticostriatal inputs from neocortical areas arise primarily from layer 5 pyramidal neurons, although layer2/3 neurons contribute to this projection as well. Two main subtypes of corticostriatal neurons are generally recognized (Wilson, 1987; Cowan and Wilson, 1994) . One, the pyramidal tract (PT) corticostriatal neuron subtype, has ipsilateral projections to the striatum, as well as collaterals to the thalamus, zona incerta (ZI), STN, SC, pontine nuclei, and to the spinal cord through the PT (Kita and Kita, 2012) . Another subtype provides bilateral projections to the striatum, with collaterals that connect primarily with other cortical areas but do not project to other subcortical areas (intertelencephalic [IT] corticostriatal neurons). BAC-Cre driver lines that preferentially express in each of these subtypes are characterized. Among these BAC-Cre driver lines, there are variations related to the cortical area of origin, with some types showing expression throughout all cortical areas, others showing restriction to specific cortical areas, and others displaying gradients of expression across cortical regions.
Based on analysis of the axonal projection profiles from AAV-expression vector injections into the cerebral cortex, BAC-Cre driver lines with expression in corticostriatal neurons are categorized into three types: (1) those with expression in both PT and IT corticostriatal neurons, which include Rbp4_KL100, Dbp_MN120, Grm2_MR90, and Sema3e_OX2; (2) those with expression restricted to PT corticostriatal neurons, which include Sim1_KJ18, Chrna2_OE25, Efr3a_NO108, and Rcan2_ON50; and (3) those with expression restricted to IT corticostriatal neurons, which include Tlx3_PL56, Ebf2_NP183, Sepw1_NP39, and Grp_KH288. The pattern of Cre-expression revealed by crosses of these lines to the Rosa26-EGFP reporter is provided in Figure S1 available online.
The BAC-Cre driver line Rbp4_KL100 may be considered a pan layer 5 line, displaying expression restricted to most layer 5 neurons throughout neocortical and periallocortical areas. AAV-vector injections in primary sensorimotor, secondary motor, and prelimbic cortical areas label axonal projections to the ipsilateral and contralateral cortex and striatum; the thalamus, STN, ZI, SC, and other midbrain structures; and the pontine nucleus and PT, indicative of labeling of PT corticostriatal neurons (Figure 2 ). Expression in IT corticostriatal neurons is indicated by bilateral labeling of projections to the striatum and cerebral cortex.
PT-Selective Layer 5 Cre Lines Four lines are described in which expression produced with AAV-vector injections is primarily restricted to layer 5 PT corticostriatal neurons. These include Sim1_KJ18, Chrna2_OE25, Efr3a_NO108, and Rcan2_ON50 (Figure 3) . Injections of AAVCre-dependent expression vectors into motor cortical areas in each of these lines label axonal projections restricted to the ipsilateral striatum, and axons in the fiber tracts that extend through the striatum into the internal capsule and cerebral peduncle to the PTs. Labeled axon collaterals extend from these projections to target the thalamus, STN and ZI, GPi, SNr, and midbrain areas BAC-Cre driver lines with expression in pyramidal neurons in layers 2/3, 4, 5, and 6 are categorized by layer, cortical area, and subtype. The number of neurons that display expression in different layers varies from line to line; some express in most pyramidal neurons in a particular layer, and others express in a subset in those layers. The cortical areas in which neurons are expressed are designated as being distributed in most cortical areas or in select areas, such as neocortical or prefrontal areas, which for the most part are periallocortical. In some lines, expression is restricted to very specific cortical areas, such as particular prefrontal areas (i.e., pre- Left column: sections displaying Cre expression with Rosa26-EGFP reporter at coronal levels through the prefrontal cortex, nucleus accumbens, striatum, thalamus, STN, zona incerta (ZI), SC, and pontine nucleus (pons). Second column: injection of AAV-dTomato Cre-dependent expression vector into the secondary motor cortex labels neurons expressing Cre and their axonal projections (pseudo-colored yellow). Labeled axons project bilaterally to the striatum, indicating labeling of IT corticostriatal neurons, and to the ipsilateral thalamus, STN, ZI, SC, and pons, indicting labeling of PT corticostriatal neurons. Injection site and axonal terminal projection areas are shown at progressively higher magnification in columns to the right. 5 neurons, with little labeling of more superficially distributed neurons. This suggests that the expression of Cre-recombinase in more superficial layer 5 neurons displayed with crosses to the reporter line is due to transient expression during development. Labeling of axonal projections with such injections display the pattern characteristic of PT corticostriatal neurons. Injections that involve the secondary motor cortex in the shoulder area result in some labeling of axons crossing to the contralateral striatum, in addition to the PT pattern of axonal labeling. The other PT-selective BAC-Cre lines label a smaller number of deep layer 5 neurons. Whereas the line Rcan2_ON50 labels neurons restricted to neocortical areas, Chrna2_OE25 and Efr3a_NO108 label neurons distributed in throughout neocortical areas as well as in periallocortical and prefrontal areas. Four BAC-Cre driver lines (Sim1_KJ18, Chrna2_OE25, Efr3a_NO108, and Rcan2_ON50) are described in which AAV-dTomato expression vector injections into primary motor cortex selectively label PT corticostriatal neurons. Cre expression in these lines is revealed by crosses to the Rosa26-EGFP reporter line that display expression in layer 5 of the cortex, shown in the top row (inset shown at higher magnification in the second row). AAV-dTomato injection sites in the motor cortex are shown in the third row, displaying labeled neurons (pseudo-colored yellow). In each line, axonal projections are distributed to the ipsilateral striatum (caudate putamen [CP]), with no evidence of projections to the contralateral hemisphere. Additionally, axonal projections are distributed through the internal capsule with axonal collaterals distributed to the thalamus, STN, SC, and pons. This pattern of axonal projections is characteristic of PT corticostriatal neurons.
IT Corticostriatal Layer 5-and Layer 2/3-Selective Cre Lines Three lines are described in which expression produced with AAV-vector injections is primarily restricted to IT corticostriatal neurons. These include Tlx3_PL56, Ebf2_NP183, Sepw1_NP39, and Gpr_KH288 ( Figure 5 ). Tlx3_PL56 and Ebf2_NP183 display expression in primary and secondary motor and sensory neocortical areas, with less expression in prefrontal cortical areas. On the other hand, Grp_KH288 displays more restricted expression primarily in secondary motor and prefrontal cortical areas. AAVCre-dependent tracer injections in Tlx3_PL56 and Ebf2_NP183 produced expression in primary motor layer 5 cortical neurons, and labeled axonal projections bilaterally within the cerebral cortex and to the striatum. There was no evidence of labeled axons in the corticofugal fiber tracts within the striatum or of labeling to nonstriatal subcortical areas. AAV-Cre-dependent tracer injections in Grp_KH288 that produced expression of prelimbic cortical neurons resulted in labeling of bilateral cortical and striatal projections, with no evidence of labeling to other subcortical structures. The pattern of axonal projections indicates that in Tlx3_PL56, Ebf2_NP183 and Grp_KH288 Cre, expression is restricted to IT corticostriatal neurons. Whether different subtypes of IT corticostriatal neurons are represented in the Tlx3_PL56 and Grp_KH288 Bac-Cre driver lines requires additional characterization (Otsuka and Kawaguchi, 2011) .
BAC-Cre driver lines with expression in cortical layers 2/3 include Sepw1_NP39, Rgs8_OK14, and Arpp21_OL90. Based on analysis of the Rosa26 reporter lines, Cre expression in the cortex is localized to layer 2/3 neurons throughout most cortical areas. Injections of AAV-Cre-dependent tracers into motor cortical areas in Sepw1_NP39 labels neurons localized in layer 2/3, bilateral axonal projections within the cerebral cortex, and bilateral projections to the striatum. There is no evidence of labeling of axonal projections to other subcortical regions, indicating that these neurons are IT corticostriatal neurons.
Prefrontal BAC-Cre Driver Lines Prefrontal cortical areas in the mouse exhibit a periallocortical laminar organization distinct from neocortical areas. This raises the question as to whether BAC-Cre driver lines with selective expression in PT and IT corticostriatal neurons in neocortical areas are similar in prefrontal areas. In some lines that express in PT or IT corticostriatal subtypes, Cre expression is limited to neocortical areas and does not extend to prefrontal areas. BAC-Cre driver lines with expression in prefrontal cortical areas are characterized in terms of select labeling of PT and IT corticostriatal subtypes. In addition, lines are described that express in select prefrontal cortical areas. Examples of AAV-expression vector labeling of axonal projections for such lines are provided in Figure 5 .
BAC-Cre driver line Colgalt2_NF107 displays reporter expression that is restricted to prefrontal cortical areas, with only sparse labeling in neocortical areas. Injections of AAV-expression vectors into the anterior cingulate and prelimbic areas result in labeling of projections bilaterally to cortical areas and the striatum, which is indicative of labeling of IT corticostriatal neurons. Axonal projections are also evident to the ipsilateral medial amygdala. In addition, axonal projections extend through the fiber fascicles through the striatum into the cerebral peduncle, with collaterals extending into the thalamus, ZI, STN, SC, and pontine nuclei. These projections are ipsilateral to the injection site and indicate labeling of PT corticostriatal neurons. Thus, Colgalt2_NF107 appears to express in both PT and IT corticostriatal neurons in the prefrontal cortex.
Some lines in which PT corticostriatal neurons selectively express Cre show limited labeling in prefrontal cortical areas (i.e., Sim1_KJ18 and Rcan2_ON50), whereas others display labeling in most neocortical and prefrontal areas (i.e., Chrna2_OE25 and Efr3a_NO108). Injections of AAV-expression vectors into medial prefrontal cortex in Chrna2_OE25 label neurons with axonal terminal projections into the ipsilateral striatum, thalamus, ZI, STN, SC, and pontine nuclei. There is no evidence of labeled projections to the contralateral hemisphere or to the ipsilateral amygdala. This pattern of axonal projections indicates selective labeling of PT corticostriatal neurons.
The two BAC-Cre lines with the most robust IT corticostriatal selective layer 5 expression in neocortical areas (Tlx3_PL56 and Ebf2_NP183) label few neurons in prefrontal areas. The Grp_KH288 line has expression selective for IT corticostriatal neurons in secondary motor areas and anterior cingulate areas, and few neurons have expression in prelimbic, infralimbic, and ventral prefrontal areas (Figure 4) . The line Sepw1_NP39 has expression selective for layer 2/3 neurons throughout most neocortical ( Figure 5 ) and periallocortical areas. Injections of AAV-expression vectors into the prelimbic cortex label neurons with axonal projections distributed bilaterally to homologous cortical areas and the striatum, as well as to the ipsilateral medial amygdala, with no evidence of projections to subcortical areas, indicative of selective labeling of IT corticostriatal neurons ( Figure 5 ).
Several BAC-Cre lines are identified that have layer-selective expression restricted to specific prefrontal areas. An example of such a line is Lypd1_NR149, with expression localized to layer 2/3 of the infralimbic prefrontal cortex. Injections of AAV-expression vectors into the medial prefrontal cortex selectively label these neurons and axonal projections distributed to the medial striatum and to the medial amygdala ( Figure 5 ). Interestingly, both of these projections are distributed only to the ipsilateral hemisphere. There is no evidence of labeling of axonal projections to nonstriatal subcortical brain regions. This pattern of axonal projections indicates selective labeling of IT corticostriatal projection neurons. Other lines with expression restricted to specific prefrontal areas include Rgs14_ SR63 with expression in agranular insular and prelimbic cortical areas.
BAC-Cre Lines with Expression in Somatosensory
Cortical Areas A number of BAC-Cre driver lines display expression, as demonstrated with the Rosa26-EGFP reporter, with expression that is somewhat restricted to specific layers within somatosensory cortical areas. These lines are listed in Table 1 and their patterns of expression are shown in Figure S2 .
BAC-Cre Line with Expression in Reward Circuits
The BAC-Cre driver line Syt17_NO14 displays expression in multiple brain areas associated with circuits involved in reward
Neuron
Cortical and Basal Ganglia Cre-Driver Lines behavior Swanson 2010, Lammel et al., 2012) . This line, crossed with the Rosa26-(CAG)dTomato reporter, displays expression in restricted cortical areas including the prelimbic, infralimbic, ventral prefrontal, and piriform cortical areas, the ventral CA1 hippocampus and dentate gyrus, intralaminar thalamic nuclei, and select hypothalamic nuclei, and is restricted to the dopamine neurons in the ventral tegmental area (with little expression in the lateral substantia nigra pars compacta dopamine neurons). The pattern of Cre expression demonstrated with the Rosa26-(CAG)dTomato reporter is more extensive than that obtained with the Rosa26-EGFP reporter, which shows robust labeling of the ventral tegmental area (VTA) dopamine neurons, but only scattered neurons in the other areas. Injections of AAV-expression vectors labeled Four BAC-Cre lines (Tlx3_PL56, Ebf2_NP183, Sepw1_NP39, and Grp_KH288) are described in which AAV-dTomato expression vector injections into primary and secondary motor cortical areas selectively label IT corticostriatal neurons. Cre expression is revealed by crosses to the Rosa26-EGFP reporter line that display expression in layer 5 in neocortical areas in Tlx3_PL56 and Ebf2_NP183, in layer 2/3 in all cortical areas in Sepw1_NP39, and in layers 5 and 2/3 in secondary motor and prefrontal areas in Grp_KH288 (top 2 rows). AAV-dTomato injection sites label neurons in the cortex, which are shown in the third row (pseudo-colored yellow). In each of these lines, axonal projections are distributed bilaterally within the cerebral cortex and CP. Axonal projections from labeled corticostriatal neurons do not extend to the internal capsule, thalamus, STN, or SC. This pattern of axonal projections is characteristic of IT corticostriatal neurons.
neurons and their axonal projections consistent with the expression pattern obtained with the Rosa26-(CAG)dTomato reporter ( Figure 6 ).
BAC-Cre Driver Lines in the Thalamus
The dorsal thalamus is an important component of basal ganglia circuitry. Various thalamic nuclei are the target of the output of 
BAC-Cre Lines with Expression in Prefrontal Cortical Areas
Four BAC-Cre lines (Colgalt2_NF107, Chrna2_OE25, Sepw_NP39, and Lypd1_NR49) display expression in prefrontal cortical areas revealed by crosses to the Rosa26-EGPF reporter (top row). AAV-dTomato expression vector injections that label neurons in the medial prefrontal cortex are shown in the second row, with insets shown at higher magnification in the third row (pseudocolored yellow). In Colgalt2_NF107, labeled prelimbic cortical neurons in layer 5 provide axonal projections bilaterally to the CP and nucleus accumbens (ACB), indicating labeling of IT corticostriatal neurons. Of note, in this case the corticostriatal projections are homogeneously distributed to both patch and matrix compartments. Additionally, axonal projections to the thalamus (not shown), ZI, STN, SC, and pons (not shown) are labeled, indicating labeling of PT corticostriatal neurons. In Chrna2_OE25, a subset of prelimbic layer 5 neurons that project to the ipsilateral striatum, thalamus (not shown), ZI, STN, SC, and pons (not shown) are labeled, indicative of selective labeling of PT corticostriatal neurons. In Sepw1_NP39, labeled prelimbic neurons in layer 2/3 provide bilateral projections to the CP, but no labeling to the thalamus, ZI, STN, SC, or pons, indicating selective labeling of IT corticostriatal neurons. In Lypd1_NR149, labeled neurons in layer 2/3 of the infralimbic cortex extend axonal projections to the ipsilateral striatum, but not to the thalamus, STN, ZI, SC, or pons, indicating selective labeling of IT corticostriatal neurons. Prefrontal injections in Colgalt2_NF107, Sepw1_NP39, and Lypd1_NR149, but not in Chrna2_OE25, result in labeling of axonal projections to the amygdala (amyg). the basal ganglia, receive collateral inputs of corticostriatal PT neurons, and provide a major source of excitatory inputs to the striatum. A number of BAC-Cre driver lines with expression in the thalamus are listed in Table 2 . Figure 7 displays the Cre expression pattern with the Rosa26-EGFP reporter line for ten of these lines. The BAC-Cre driver line Slc7a6_OX30, which uses the gene promoter for the vesicular glutamate transporter subtype 2 (Vglut2), displays expression in most dorsal thalamic 
BAC-Cre Line Syt17_NO14 with Expression in Reward Circuits
Cre-induced expression is demonstrated in BAC-Cre line Syt17_NO14 by crosses to the Rosa26_(CAG)dTomato reporter line in coronal sections at the level of the prefrontal cortex, ACB, striatum (CP), thalamus, amygdala (amyg), and midbrain (pseudocolored green in the left-hand column). Injections of AAV-dTomato expression vectors into areas expressing Cre label neurons (top row) and their axonal projections, shown in the column below in matched coronal levels (pseudocolored yellow). Injection case 385 labeled prelimbic cortical neurons, which provide axonal projections bilaterally to the striatum (CP) and amygdala, indicative of labeling of IT corticostriatal neurons and projections to the STN, SC, and pons, indicative of labeling of PT corticostriatal neurons. In this case, there is retrograde labeling of intralaminar thalamic neurons. Injection case 006 labeled intralaminar thalamic neurons, which provide axonal projections to the prelimbic cortex, ipsilateral striatum (CP and ACB), and retrosplenial cortical areas. Injection case 356 labeled ventral CA1 hippocampal neurons, which provide axonal projections to the prelimbic cortex, ACB, lateral septal nucleus (LS), hypothalamus (hypo), and amygdala. Injection case 756 labeled ventral tegmental area (VTA) dopamine neurons, which provide axonal projections to the prelimbic cortex, ACB, ventral CP, and amygdala. nuclei neurons. Other BAC-Cre driver lines display expression that is restricted to select dorsal thalamic nuclei.
In addition to inputs from the cerebral cortex, the other major source of excitatory inputs to the striatum arises from the intralaminar nuclei of the thalamus. Several BAC-Cre lines are identified with expression selectively in thalamic intralaminar nuclei, including Syt17_NO14, Plxnd1_OG1, Grp_KH288, and Syt17_NO14. Injections of AAV expression vectors into the intralaminar nuclei in each of these lines resulted in selective labeling of neurons in the intralaminar thalamic nucleus and axonal projections to the striatum and cortical areas (Figures 6 and S3 ).
Striatal Circuits
The main neuron subtype in the striatum is the spiny projection neuron, which constitutes as much as 90% of the striatal neuron population. There are two main subtypes of striatal spiny projection neurons distinguished by their axonal projections (Kawaguchi et al., 1990) . One gives rise to the striatal direct pathway as it projects to the output nuclei of the basal ganglia, the internal segment of the GPi, and substantia nigra, while the other gives rise to the indirect striatal pathway, which projects to the external segment of the GPi, which through connections with the STN provides indirect connections to the output nuclei of the basal ganglia. Direct and indirect striatal projection neurons are distinguished by their respective selective expression of the Drd1a and Drd2 dopamine receptors, as well as other neurochemical markers (Gerfen et al., 1990) .
A list of the BAC-Cre driver lines with expression in the striatum is provided in Table 3 . Lines are identified with expression in both direct and indirect pathway neurons, selective for either the direct or indirect pathway neurons, restricted to striatal regions, and show some preferential distribution in either the patch or matrix compartments.
Of particular utility are lines that differentially express Cre in striatal direct or indirect pathway neurons ( Figure S4 ). The Drd1a BAC-Cre driver lines provide labeling of direct pathway neurons and not indirect pathway neurons. The Drd1a BACCre driver lines display different patterns of expression. Two Drd1a lines, FK150 and FK162, display expression that matches the full pattern of endogenous expression of the Drd1a gene, with expression throughout the striatum, in select cortical neurons, amygdala, and hypothalamus. Other lines display expression in subsets of the full Drd1a expression pattern. Drd1a_EY217 displays expression throughout the dorsal striatum, with limited expression in the cortex and ventral striatum. Depending on the experimental paradigm different Drd1a BACCre driver lines may be used for studies of the direct striatal pathway. BAC-Cre lines that label the indirect striatal pathway include Drd2-ER44 or Adora2a-KG126. While the Drd2_ER44 and Adora2a_KG126 lines label indirect and not direct spiny projection neurons, these genes are also expressed in striatal interneurons. The possibility that these BAC-Cre lines express in striatal interneurons must be taken into consideration.
Other BAC-Cre lines display expression in the striatum selective for the patch and matrix compartments (described below) or display other patterns of restricted expression. These include Kcnip2_OP11 with expression in the lateral striatal matrix compartment and lateral striatal patches, Gabrr3_KC112 with expression restricted to a lateral region of the striatum, and Sema3e_OX2 with expression restricted to the dorsomedial striatum. The BAC-Cre driver line Chrna2_NP306 is particularly interesting because it displays expression in striatal spiny projection neurons that are scattered throughout the striatum in a manner that there appears to be little overlap of dendritic arbors of labeled neurons.
Patch/Matrix BAC-Cre Lines
Overlying the homogeneous organization of the direct and indirect striatal pathways, there are two distinct macroscopic compartments, termed the patch/striosome and matrix compartments, that are defined according to the expression of various neurochemical markers and the organization of inputs from the cerebral cortex, thalamus, and midbrain dopamine neurons, and their differential projections (Gerfen, 1992) . Corticostriatal inputs to the patch and matrix compartments arise from distinct populations of layer 5 cortical neurons (Gerfen, 1989) , and neurons in the patch and matrix compartments project respectively to dopamine neurons in the substantia nigra pars compacta (SNc) or to GABAergic neurons in the SNr (Gerfen, 1992) . BAC-Cre driver lines that preferentially express in these patch/striosome and matrix circuits are characterized.
The BAC-Cre line Plxnd1_OG1 displays expression in corticostriatal neurons projecting primarily to the striatal matrix compartment. Injections of AAV-Cre dependent expression vectors that label select neurons in layer 5, and some in layer 2/3 in the primary motor cortex, label axonal projections that are distributed primarily into the striatal matrix compartment bilaterally (Figure 8 ). Although there is substantial labeling of corticostriatal projections with cortical injections in this line, there is only sparse labeling of projections to other subcortical regions, including the thalamus and SC, and some labeling of fibers extending through the internal capsule and cerebral peduncle to the PT. This pattern of labeling suggests that the predominant matrix-directed corticostriatal neurons are of the IT subtype. To date, no BAC-Cre driver lines have been identified with expression strictly restricted to corticostriatal neurons selectively project to the patch/striosome compartment. One line, Colgalt2_NF107, displays Cre expression that has some selectivity for such neurons. Expression in this line, displayed with the Rosa26-reporter lines, shows somewhat preferential labeling of corticostriatal terminals in the patch/striosome compartment, although there is clear labeling in both compartments. Injections of AAV vectors in this line reveal both patterns of labeling. In some cases (Figure 5 ), injections into the medial prefrontal cortex label axonal projections that are distributed bilaterally to the striatum in a somewhat homogeneous pattern. On the other hand, other injections into the medial prefrontal cortex label corticostriatal axons that display a preferential distribution in the striatal patch/striosome compartment (Figure 8 ). Similar patterns of preferential patch projections are also seen with injections in the prefrontal and motor cortical areas in Syt17_NO14. This suggests that the use of these lines may provide selective labeling of corticostriatal neurons with selective inputs to the patch/ striosome compartment.
The BAC-Cre line Plxnd1_OG1 also displays expression in the striatum, restricted to spiny projection neurons in the matrix compartment. Injections of AAV vectors into the striatum selectively label neurons in the matrix compartment and axonal projections distributed in the GPe and into the substantia nigra. Axonal labeling in the substantia nigra is restricted to the SNr, with few terminals directed to the location of dopamine neurons in the substantia nigra pars compacta (SNc). This pattern of labeling suggests labeling of both striatal direct and indirect pathway neurons in the matrix compartment. Expression in Plxnd1_OG1 is somewhat restricted to the dorsal half of the striatal matrix compartment. Another Bac-Cre line, Npyr1_RL2, also selectively labels striatal matrix neurons, which are distributed through all regions of the striatum, including the ventral regions ( Figure S5 ). 
BAC-Cre Lines with Expression in Thalamic Nuclei
Immunohistochemical Cre-induced EGFP labeling produced by Rosa26_EGFP reporter in ten lines with expression in various thalamic nuclei. Slc17a6_OX30 (gene also known as Vglut2) has Cre expression in most thalamic nuclei. Other lines show selective expression in thalamic nuclei: Kcnc1_MN77 (MD, VPM, VPL, and SMT), Grm2_MR90 (AV, LD, IL, PVT, LH, and MH), Gpr26_KO250 (LD, VAL, and VM), Vipr2_KH234 (VPM and VPL), Nelf_NR133 (VPM and VPL), Crh_KN282 (VPM and VPL), Gsbs_NL146 (VPM, VPL, and SMT), Cnnm2_KD19 (MH), and Hap1_RE55 (LH and VM). See Table 3 for a complete list.
Three lines (Sepw1_NP67, Syt6_KI148, and Dlg3_KG118) exhibit preferential labeling in striatal patch neurons, as determined by the relationship of labeled neurons to the neurochemical patch marker mu opiate receptor immunohistochemistry. In each of these lines, there is some labeling of scattered neurons in the striatal matrix compartment. Injections of AAV vectors into the striatum in Sepw1_NP67 label neurons preferentially localized in the striatal patch compartment, with some scattered neurons in the matrix. Labeling of axonal projections to the substantia nigra shows preferential labeling terminating in the location of dopamine neurons in the SNc. In this case, there is some labeling of axonal terminals in the SNr, which may be attributed to labeling of some axons of patch neurons and the scattered neurons in the striatal matrix. The patterns of labeling of axonal projections of striatal patch/striosome (Sepw1_NP67) and matrix neurons (Plxnd1_OG1) are consistent with the established differential projections of these striatal compartments to the SNc and SNr (Gerfen, 1992; Fujiyama et al., 2011; WatabeUchida et al., 2012) .
Additional BAC-Cre Driver Lines
The GENSAT BAC-Cre driver line collection contains lines that display selective expression in many brain areas related to cortical and basal ganglia circuits in addition to those described above. Information on these lines is available on the GENSAT websites (http://www.gensat.org/cre.jsp and http://GENSATcreBrains. net). A list of these lines is provided in Table 4 . Included are lines with expression in the amygdala, hippocampus, neurotransmitter-specific neurons (including dopamine, noradrenergic, serotonergic, and cholinergic neurons), and components of the basal ganglia circuits (including the habenula, STN, and SC). Lines that display Cre expression in the intermediate layer of the SC, which is the target of the output SNr, are shown in Figure S6 . Additionally, there are lines that express in GABAergic and peptidergic interneurons in the cerebral cortex and striatum. A more complete collection of GABAergic interneurons has been provided in a recent study (Taniguchi et al., 2011) .
DISCUSSION
The GENSAT project has produced over 250 BAC-Cre driver lines that are available to the research community (Gong et al., 2007) . These lines utilize BAC constructs that are modified by replacing the coding sequence for the protein of the gene of interest with Cre-recombinase. An advantage of this approach is that, in most cases, the BAC constructs contain the entire promoter region of the gene, which is essential for regulating expression of its coding sequence (Heintz, 2001) . In most cases, Creexpression mimics the expression of the endogenous gene. On the other hand, for some BAC-Cre driver constructs, the expression pattern in a specific line displays expression patterns that might not be predicted from the endogenous gene expression, most likely due to the genomic site into which the BAC construct is inserted. Nonetheless, such lines often produce expression in specific neuron populations and are stable. Additionally, the use of BAC constructs to drive Cre expression allows targeted neurons to be functionally manipulated without affecting the function of the endogenous gene. The utility of these lines for use in combination with other techniques to address functional questions is dependent on determining the specific neuron subtypes in which Cre-recombinase is functionally expressed. Expression data provided with Rosa26-reporter lines provide valuable information but are limited by inherent limitations due to transient expression of some genes during development and the sensitivity of the reporter lines used. In this study, we provide additional characterization based on injection of Cre-dependent AAV-expression vectors to identify specific subtypes of neurons. Data from such injections are predictive of the neurons in a given BAC-Cre line that will be infected with similar AAV vectors with Cre-dependent constructs to express proteins used to functionally activate or record physiologic activity. Additionally, data provided by AAV-expression vectors allow for the identification of neuron subtypes on the basis of their axonal projections.
In this study, over 30 BAC-Cre lines are described with expression in the cerebral cortex. The specific cortical subtypes that express functional Cre vary in these lines as determined with AAV-expression vector injections. Some lines have expression that is specific for particular layers and for the IT and PT layer 5 subtypes. These include Sepw1_NP39 for layer 2/3, Tlx3_PL56 for layer 5 IT corticostriatal neurons, Sim1_KJ18 for layer 5 PT corticostriatal neurons, and Ntsr1_GN220 for layer 6 corticothalamic neurons. Other lines label subsets of the neuron subtypes or label subsets of neurons in multiple layers. These lines may be useful for identifying additional subtypes of cortical neurons or for determining specific connections between neurons in different cortical layers. These BAC-Cre driver lines provide research tools for addressing questions concerning the functional role of specific neuron circuits in behavior. Recent studies have begun to elaborate principles of functional connectivity within the cerebral cortical circuits (Molyneaux et al., 2007) . Patterns of connectivity between pyramidal neurons suggest the organization of excitatory networks that segregate functional pathways for processing different types of information (Otsuka and Kawaguchi, 2011; Morishima et al., 2011) . These networks are formed by connections between cortical areas that differentially target layer 2/3 neurons and PT and IT layer 5 neurons (Mao et al., 2011) , by differential connections from layer 2/3 neurons onto PT and IT layer 5 neurons (Anderson et al., 2010) , by a differential probability of connections between PT and IT layer 5 neurons (Brown and Hestrin, 2009) , and by differential connections of layer 5 neurons with the thalamus (Hooks et al., 2013) . These distinct functional channels of excitatory networks are suggested to differentially regulate the output of PT and IT corticostriatal neurons (Morita et al., 2012; Shepherd 2013) .
Patterns of segregated excitatory circuits are proposed to underlie the integration of sensory and motor representations within motor cortical areas involved in sensorimotor learning (Huber et al., 2012) . One of the findings of this study is that intermingled neurons of a particular cortical subtype differentially encode sensory and motor information. This suggests that there are functionally distinct subtypes of particular types of cortical neurons. Other studies have identified subtypes of PT and IT corticostriatal neurons based on their dendritic morphology Left panels: in lines Plxnd1_OG1 and Colgalt2_NF107, Cre-induced EGFP expression produced with the Rosa26_EGFP reporter is shown in the cortex (top row) and striatum (bottom row). Injections of AAV-dTomato expression vectors in Plxnd1_OG1 label neurons in the somatosensory cortex that provide projections selectively distributed in the striatal matrix compartment (pseudo-colored yellow), whereas injections in Colgalt2_NF107 label neurons in the prelimbic cortex, which in this case distribute projections to the striatal patch compartment. Right panels: striatal patch/matrix projections to the substantia nigra. Top row: Creinduced EGFP expression produced with the Rosa26_EGFP reporter displays expression in neurons selectively in the striatal matrix (Plxnd1_OG1) and patch (Sepw1_NP67) compartments. Injections of AAV-dTomato expression vectors into the striatum in line Pxnd1_OG1 selectively label neurons in the matrix compartment with axonal projections that terminate in the SNr, which does not contain dopamine neurons (labeled red). In contrast, injections into the striatum in line Sepw1_NP67 label neurons preferentially in the patch compartment, which provide axonal projections to the substantia nigra that target the dopamine neurons in the pars compacta (labeled red), with some terminals in the pars reticulata.
and physiologic characteristics (Otsuka and Kawaguchi, 2011; Morishima et al., 2011) . The BAC-Cre driver lines described in this study with selective expression in PT and IT corticostriatal neurons display differences that suggest that different subtypes of these neurons may express functional Cre in different lines. Such differences are apparent both within particular cortical areas and between cortical areas. Further characterization of these subtypes of Cre-expressing PT and IT neurons is necessary to determine whether they correspond to subtypes with distinct physiologic and connectional properties.
The specificity of connections between subtypes of cortical pyramidal neurons provides a neuroanatomical substrate for processing distinct types of information in functional channels within the organization of cerebral cortical circuits. Understanding how such channels affect behavior depends on determining how the output of these channels is organized through connections to their targets in subcortical circuits. In a previous study, Gerfen (1992) showed that segregation of different cortical inputs is maintained by connections of the striatal patch and matrix compartments, and thus established the existence of functional channels at a macroscopic level in corticostriatal circuits. As discussed above, recent studies suggest that specificity between connections within the cerebral cortex establish distinct functional channels for PT and IT corticostriatal neurons. The report that PT and IT corticostriatal neurons selectively project to direct and indirect striatal neurons, respectively, suggests that the segregation of excitatory networks in cerebral cortical circuits extends into the striatum (Lei et al., 2004) . These studies suggest that a general principle of the organization of functional excitatory circuits within the cortex is the high degree of specificity in the patterns of connectivity of distinct subtypes of cortical pyramidal neurons. The availability of BAC-Cre driver lines that allow targeting of subtypes of cortical neurons provides a research tool for determining not only the specificity of intracortical connections but also the specificity of connections to defined neurons in the striatum. Such studies may then be extended to determine how functional excitatory cortical circuits affect behavior.
EXPERIMENTAL PROCEDURES
Mice were maintained in an IACUC-approved NIH shared animal facility, and all experimental procedures were conducted in accordance with NIH ethical guidelines under an Animal Study Protocol approved by the Animal Care and Use Committee of the Division of Intramural Research Programs, NIMH.
Mice BAC-Cre transgenic mouse lines were created using BAC engineering techniques as described previously (Gong et al., 2003 (Gong et al., , 2007 . BAC vectors containing the target gene of interest were modified in the following manner: Immediately after the initiating ATG codon in the first coding exon of the selected gene, an intron containing a Cre-recombinase cassette was inserted. This was followed by a polyadenylation sequence to terminate transcription of the fusion transcript immediately after the recombinase gene. This was done using a shuttle vector (pLD53.SC-Cre) carrying the appropriate selectable markers, and a small homology arm from the locus being targeted to guide recombination. To characterize functional Cre-expression, mice were crossed to the Rosa26/stop/EGFP reporter line (Soriano, 1999) . Brains from mice carrying both the BAC-Cre construct and Rosa26_EGFP transgene were processed for immunohistochemical detection of EGFP using either peroxidase or indirect fluorescent labeling. Some lines were also crossed to the Rosa26_CAG-tdTomato Ai9 reporter line (B6;129S6-Gt(ROSA)26Sortm9(CAG-tdTomato) Hze/J from the Allen Institute for Brain Science; Madisen et al., 2010) . Functional reporter expression in brain sections was detected either by direct fluorescent observation or by immunohistochemical detection of tdTomato.
AAV-Expression Vector Injections
To trace axonal projections of Cre-expressing neurons in the BAC-Cre transgenic lines, we injected the EGFP and tdTomato AAV Cre-dependent 
